SeaStar Medical Holding (ICU) - Cash per Share

SeaStar Medical Holding (ICU) brings together scientists to combat systemic inflammation, relying on ethics and R&D autonomy. This chart provided by the GURU.Markets system shows that the cash per share figure demonstrates balance sheet liquidity, while the 0.75 value captures the metric level. Selective cytokine removal technology saves patients with multi-organ failure, and the FDA HDE status blocks competitors from entering the kidney therapy niche.
Analytical breakdowns for SeaStar Medical Holding

For SeaStar Medical Holding, the cash per share chart reflects the medtech manufacturer's financial resilience in the face of geopolitical risks. This metric is calculated by dividing total cash by the total number of shares. The narrowing volatility of this metric signals liquidity stabilization before a potential move beyond the standard deviation. For ICU, this serves as a means of protecting supply chains and patent rights. Resource accumulation determines the balance between expansion and the risk of inefficient capital utilization.